Literature DB >> 20822757

Glioblastoma multiforme mimicking a frontal abscess after surgery for a large vestibular schwannoma.

C Fuchsmann1, A Traverse-Glehen, M Durbec, C Dubreuil, S Tringali.   

Abstract

OBJECTIVES: Routine vestibular schwannoma surgery can result in serious and potentially lethal infectious complications. A high degree of vigilance is necessary to diagnose these uncommon infections and in case of postoperative neurological symptoms, brain magnetic resonance imaging should be performed to eliminate a brain abscess. In some cases, the final diagnosis is not the expected one. CLINICAL
PRESENTATION: A 39-year-old man presented three months postoperatively after a vestibular schwannoma removal by translabyrinthin approach with a rapid and progressive history of headaches, confusion, and left hemi paresis with fever. The brain CT and MRI were in favour of a delayed postoperative frontal abscess. TECHNIQUE: A biopsy under stereotactic guidance was performed. Histopathologic examination revealed WHO grade 4 glioblastoma multiforme.
CONCLUSION: Symptoms and signs of glioblastoma multiforme are congruent with brain abscess. Its rapid evolution, the normality of the first magnetic resonance imaging, and its radiological aspect made it a differential diagnosis of a postoperative brain abscess and should be systematically researched.
Copyright © 2010. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2010        PMID: 20822757     DOI: 10.1016/j.anorl.2010.02.011

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN: 1879-7296            Impact factor:   2.080


  1 in total

1.  The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses.

Authors:  Diana Horvath-Rizea; Alexey Surov; Karl-Titus Hoffmann; Nikita Garnov; Cathrin Vörkel; Patricia Kohlhof-Meinecke; Oliver Ganslandt; Hansjörg Bäzner; Georg Alexander Gihr; Marcell Kalman; Elina Henkes; Hans Henkes; Stefan Schob
Journal:  Oncotarget       Date:  2018-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.